Clinical Trial Update: Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab with vinorelbine in elderly patients with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED